Trading Conditions

Platform
MT5
MT5
Execution
Market Execution
Market Execution
MT5Floating spreads
Minimum: 11.00Average: 11.41
Market Hours*Closed Now
Market Hours*Closed Now
TickerCCCC.O
Limit and Stop Level10
1 tick value per share0.01 USD
Minimum contract size20 share
CommissionNo
Minimum Price Fluctuation0.01 USD
Minimum step for increasing contract size0.01 share
Margin requirements to open a lock position *0
Maximum Trade Size1000
Maximum exposure per share per account, USD100 000

* Only if Margin Level > 100%

The average spreads provided for each platform are updated on a daily basis to reflect the average for the previous day. Though FxPro attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. FxPro has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions of Business'.

Explore the dynamic world of C4 Therapeutics Inc shares on FxPro. Get up-to-date information on the real-time share price, overall market trends, and economic insights. Understand C4 Therapeutics Inc's market position with our comprehensive analysis, featuring historical data and future prospects. Stay updated about the recent market developments and how they impact C4 Therapeutics Inc's share value. Start trading with FxPro today and leverage the potential of C4 Therapeutics Inc's shares in your investment portfolio.

C4 Therapeutics Inc is a biopharmaceutical company specialising in methodology for the treatment of cancer, neurodegenerative conditions and other diseases through the development of new therapeutic products. They are based on the use of the natural regulation of protein levels in the body for the targeted destruction of those that cause disease.

CCCC.O's approach is to use proteolysis technology (the process of cleaving one or more peptide bonds in a protein molecule using enzymes). Simply put, it allows to calculate disease-causing proteins and destroy them. To date, there are several developments at the stage of preclinical trials. Two programs will enter the first clinical phase at the end of 2021, the other two at the end of 2022.

C4 Therapeutics Inc went public in October 2020 and has been in the focus of traders' ever since.

Traders deservedly consider this stock one of the most visible on the market due to its volatility and unpredictability. Beginners will find it quite difficult to keep up with the stock price of C4 Therapeutics Inc. However, if you understand the general correlations and monitor how the chart reacts to certain news, you may be able to make effective trades. You can buy and also sell this asset as a CFD, speculating on the price changes.

You can see Bid and Ask online prices in real-time on this page. However, the most accurate quotes are waiting for you in trading terminals.

Please note that in the case companies issue a dividend, the ex-dividend date, that is the date without entitlement to the dividend, is known in advance and is displayed in the corresponding calendar on our website. If you have a Buy position open on the ex-dividend date, your trading account will be credited with the dividend net of any withholding taxes. In the case of holding a Sell position, the whole dividend will be debited to your account. If you have questions about this, our customer support team are on hand to assist.

Start Trading on CCCC.O CFD Stocks with FxPro Today!